Register Now
Course Information

About the Symposium

Welcome to the Mellen Center Update in Multiple Sclerosis (MS) 2022. This is our 14th symposium and we hope you’ll find the agenda as fascinating as we do. The program is intended to have something for everyone, from the practical day-to-day management of MS patients to the newest research developments in the field.

This year we are excited to welcome Dr. Peter Calabresi from Johns Hopkins University as our keynote speaker. Dr. Calabresi has had a distinguished career in the field of MS and has been a leader in the development of neurofilament light chain as a biomarker to monitor the disease process. His talk will help us to understand clinical and research applications of this important new tool. Additionally, Dr. Jeffrey Cohen will speak on hematopoietic stem cell transplantation and how we can best choose patients for this promising procedure. Dr. Robert Fox will give an update on the management of progressive MS, including possible therapeutics on the horizon.

We will have three tracks in the afternoon designed to appeal to a wide range of interests. The first is a track on the management of MS and will include talks from Dr. Daniel Ontaneda on how widely we should be using B-cell depletion in MS and from Dr. Brandon Moss on management of MS patients in the era of COVID-19. The second track is titled “Demystifying the Disability Application Process.” Obtaining disability benefits can be a confounding and frustrating process for both patients and clinicians and we hope that input from our experts, including Allyson Krueger from social work, Christina Duncan from occupational therapy, and Dr. Rachel Galioto, our neuropsychologist, will help to clarify the necessary steps. Finally, our MS Management Track will cover an array of interesting topics including a talk on unusual demyelinating disorders from Dr. Alise Carlson and a review by Dr. Deja Rose of how healthcare disparities can impact MS patients. The track will conclude with a panel discussion by our advanced practice clinicians on how to handle difficult situations in the MS clinic.

We welcome you to join us virtually for the event and believe you will find the program stimulating and entertaining. We hope to resume in-person programming in 2023 and will definitely look forward to meeting our attendees face-to-face again.

Best Regards,


Devon Conway, MD, MS - Symposium Director

Objectives

At the completion of this activity, the participant will be able to:

  • Summarize research insights on the pathophysiology of MS and their potential implications for clinical practice.
  • Explain emerging concepts in MS management including immunoablation with hematopoietic stem cell transplantation and B cell depletion.
  • Describe recent developments in the management of pediatric-onset MS.
  • Characterize the diagnosis and management of non-MS central nervous system inflammatory disorders.
  • Critically appraise the evidence on how COVID-19 affects the care of patients with MS.
  • Detail the disability process in multiple sclerosis focusing on physical evaluations and cognitive assessments.
  • Summarize how management strategies for multiple sclerosis are affected by healthcare disparities and mental health disorders.

Target Audience

This update is intended for health care practitioners engaged in the care of patients with MS and related disorders. We will cover a broad range of topics of value to the health care professional and allow for interaction time with attendees. It will also be valuable for those involved in rehabilitation of patients with MS.